International Journal of Pharmacology1811-77751812-5700Asian Network for Scientific Information10.3923/ijp.2016.86.91AmrAbd El-Galil E. Al-OmarMohamed A. AbdallaMohamed M. 22016122Ten pyridine and pyrimidine and thiazolopyrimidine derivatives (1-10) were synthesized and screened as analgesic, anticonvulsant and antiparkinsonian agent beforeTen pyridine and pyrimidine and thiazolopyrimidine derivatives (1-10) were synthesized and screened as analgesic, anticonvulsant and antiparkinsonian agent before. Herein, all the target compounds showed anti-inflammatory activity. The active compounds showed selective inhibitory activity towards COX-2 enzyme as revealed by the in vitro enzymatic assay. All the tested compounds proved to have superior gastrointestinal (GI) safety profiles as compared to indomethacin, when tested for their ulcerogenic effects.]]>Abouzeit-Har, M.S., T. Verimer and J.P. Long,198237593595Allison, M.C., A.G. Howatson, C.J. Torrance, F.D. Lee and R.I.N. Russel,1992327749754Amr, A.E.G.E., H.H. Sayed and M.M. Abdalla,2005338433440Beers, S.A., E.A. Malloy, W. Wu, M. Wachter and J. Ansell et al.,1997N-(5-substituted) thiophene-2-alkylsulfonamides as potent inhibitors of 5-lipoxygenase.]]>5779786Bekhit, A.A. and H.T.Y. Fahmy,2003H-pyrazolyl-oxazolidines or 1H-pyrazolyl-thiazolidines as anti-inflammatory-antimicrobial agents.]]>336111118Bekhit, A.A., H.M.A. Ashour, Y.S.A. Ghany, A.E.A. Bekhit and A. Baraka,2008H-pyrazole as anti-inflammatory antimicrobial agents.]]>43456463Chan, C.C., S. Boyce, C. Brideau, S. Charleson and W. Cromlish et al.,1999H)-furanone]: A Potent and Orally Active Cyclooxygenase-2 Inhibitor. Pharmacological and Biochemical Profiles.]]>290551560Chandrasekharan, N.V., H. Dai, K.L.T. Roos, N.K. Evanson, J. Tomsik, T.S. Elton and D.L. Simmons,2002991392613931Di Rosa, M. and D.A. Willoughby,197123297298Flower, R.J.,20032179191Hu, J., Y. Wang, X. Wei, X. Wu and G. Chen et al.,201364292301Litchfield, Jr. J.T. and F. Wilcoxon,19499699113Myakushkene, G., E. Udrenaite, P. Gaidyalis and P. Vainilavichyus,1999332426Palomer, A., F. Cabre, J. Pascual, J. Campos and M.A. Trujillo et al.,20024514021411Salimi, M., M.H. Ghahremani, N. Naderi, M. Amini and M. Salimi et al.,20072812541260Sondhi, S.M., M. Johar, N. Singhal, S.G. Dastidar, R. Shukla and R. Raghubir,2000131511520Sondhi, S.M., M. Johar, S. Rajvanshi, S.G. Dastidar, R. Shukla, R. Raghubir and J.W. Lown,2001546974Sondhi, S.M., R.P. Verma, N. Singhal, R. Shukla, R. Raghubir and M.P. Dubey,1999365054Song, Y., D.T. Connor, R. Doubleday, R.J. Sorenson and A.D. Sercel et al.,1999in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.]]>4211511160Sontag, S.J.,198632445457Tietz, O., S.K. Sharma, J. Kaur, J. Way, A. Marshall, M. Wuest and F. Wuest,201318F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold.]]>1180528064Tsuji, K., K. Nakamura, T. Ogino, N. Konishi and T. Tojo et al.,199846279286Venu, T.D., S.A. Khanum, A. Firdous, B.K. Manuprasad, S. Shashikanth, R. Mohamed and B.S. Vishwanth,20081844094412Verma, M., M. Tripathi, A.K. Saxena and K. Shanker,199429941946Wakitani, K., T. Nanayama, M. Masaki and M. Matsushita,199878365371